MENU
KOD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Kodiak Sciences (KOD) Earnings Date & Reports
Kodiak Sciences Inc has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) platform, for retinal medicines... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
KOD is expected to report earnings to rise 6.38% to -100 cents per share on November 12
Q3'26
Est.
$-1.00
Q1'26
Missed
by $0.15
Q4'25
Missed
by $0.03
Q3'25
Missed
by $0.14
Q2'25
Beat
by $0.01
The last earnings report on May 07 showed earnings per share of -93 cents, missing the estimate of -79 cents. With 1.05M shares outstanding, the current market capitalization sits at 2.06B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of novel therapies for the treatment of retinal disease
Industry Biotechnology
Profile
Details
Industry
Biotechnology
Address
1250 Page Mill Road
Phone
+1 650 281-0850
Employees
124
Web
https://www.kodiak.com